Edwards Lifesciences Corp. (EW) Tops Q1 EPS by 7c, Updates Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
- US orders diplomats to depart Saudi Arabia amid Houthi strikes
Edwards Lifesciences (EW) Target Lifted to $94 at Jefferies Post Q1
April 25, 2014 11:17 AM EDTJefferies analyst Raj Denhoy lifted estimates and his price target on Buy-rated Edwards Lifesciences (NYSE: EW) price target of $94.00 (from $72.00) following solid Q1 results.
Denhoy SAID, "1Q TAVR upside was fueled by notable strength in Europe... More



